Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |